Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 2
1955 3
1956 1
1957 4
1958 1
1959 4
1960 3
1961 1
1962 11
1963 6
1964 10
1965 5
1966 6
1967 10
1968 16
1969 13
1970 17
1971 12
1972 8
1973 15
1974 10
1975 21
1976 23
1977 20
1978 27
1979 27
1980 29
1981 26
1982 32
1983 33
1984 41
1985 41
1986 41
1987 53
1988 61
1989 79
1990 66
1991 60
1992 61
1993 82
1994 65
1995 68
1996 69
1997 89
1998 80
1999 65
2000 75
2001 75
2002 71
2003 89
2004 79
2005 92
2006 96
2007 95
2008 97
2009 107
2010 113
2011 135
2012 169
2013 165
2014 156
2015 184
2016 162
2017 177
2018 146
2019 163
2020 180
2021 207
2022 187
2023 133
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

4,255 results

Results by year

Filters applied: . Clear all
Page 1
Distinct transcriptome architectures underlying lupus establishment and exacerbation.
Nakano M, Ota M, Takeshima Y, Iwasaki Y, Hatano H, Nagafuchi Y, Itamiya T, Maeda J, Yoshida R, Yamada S, Nishiwaki A, Takahashi H, Takahashi H, Akutsu Y, Kusuda T, Suetsugu H, Liu L, Kim K, Yin X, Bang SY, Cui Y, Lee HS, Shoda H, Zhang X, Bae SC, Terao C, Yamamoto K, Okamura T, Ishigaki K, Fujio K. Nakano M, et al. Cell. 2022 Sep 1;185(18):3375-3389.e21. doi: 10.1016/j.cell.2022.07.021. Epub 2022 Aug 22. Cell. 2022. PMID: 35998627 Free article.
Immune organoids: from tumor modeling to precision oncology.
Dao V, Yuki K, Lo YH, Nakano M, Kuo CJ. Dao V, et al. Among authors: nakano m. Trends Cancer. 2022 Oct;8(10):870-880. doi: 10.1016/j.trecan.2022.06.001. Epub 2022 Jun 27. Trends Cancer. 2022. PMID: 35773148 Free PMC article. Review.
Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases.
Ota M, Nagafuchi Y, Hatano H, Ishigaki K, Terao C, Takeshima Y, Yanaoka H, Kobayashi S, Okubo M, Shirai H, Sugimori Y, Maeda J, Nakano M, Yamada S, Yoshida R, Tsuchiya H, Tsuchida Y, Akizuki S, Yoshifuji H, Ohmura K, Mimori T, Yoshida K, Kurosaka D, Okada M, Setoguchi K, Kaneko H, Ban N, Yabuki N, Matsuki K, Mutoh H, Oyama S, Okazaki M, Tsunoda H, Iwasaki Y, Sumitomo S, Shoda H, Kochi Y, Okada Y, Yamamoto K, Okamura T, Fujio K. Ota M, et al. Among authors: nakano m. Cell. 2021 May 27;184(11):3006-3021.e17. doi: 10.1016/j.cell.2021.03.056. Epub 2021 May 1. Cell. 2021. PMID: 33930287 Free article.
Leveraging big data of immune checkpoint blockade response identifies novel potential targets.
Bareche Y, Kelly D, Abbas-Aghababazadeh F, Nakano M, Esfahani PN, Tkachuk D, Mohammad H, Samstein R, Lee CH, Morris LGT, Bedard PL, Haibe-Kains B, Stagg J. Bareche Y, et al. Among authors: nakano m. Ann Oncol. 2022 Dec;33(12):1304-1317. doi: 10.1016/j.annonc.2022.08.084. Epub 2022 Aug 30. Ann Oncol. 2022. PMID: 36055464 Free article. Review.
Foreword.
Nakano M. Nakano M. Chem Pharm Bull (Tokyo). 2022;70(8):506. doi: 10.1248/cpb.c22-ctf7008. Chem Pharm Bull (Tokyo). 2022. PMID: 35908913 Free article. No abstract available.
Reply by Authors.
Shoji S, Kaya T, Tanaka Y, Uemura K, Kusaka T, Takahashi K, Yuzuriha S, Kano T, Hanada I, Umemoto T, Ogawa T, Nakano M, Kawakami M, Nitta M, Hasegawa M, Hashida K, Hasebe T, Kaneko T, Okada J, Asai S, Miyajima A. Shoji S, et al. Among authors: nakano m. J Urol. 2023 Jan;209(1):197. doi: 10.1097/JU.0000000000002958.02. Epub 2022 Sep 28. J Urol. 2023. PMID: 36169486 No abstract available.
4,255 results